Pharmaceutical News and Articles

Autoimmune Diseases Linked to Digestive System Cancers

Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine. Julia Rei

High Metabolic Syndrome Severity Linked to Development of CKD

High metabolic syndrome (MetS) severity, expressed by the continuous metabolic syndrome severity score (cMetS-S), is associated with development of chronic kidn

FDA Approves Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the Treatment of Fibromyalgia

Centenarians Have Fewer Diseases, Develop Them More Slowly

Centenarians have lower overall disease burden, delayed onset of multiple conditions, and fewer cooccurring diseases over time, according to a study published o

Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint

CAMBRIDGE, Mass., August 13, 2025 Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointe

Sleeping Sickness Eliminated in Kenya, WHO Says

THURSDAY, Aug. 14, 2025 The World Health Organization (WHO) has recognized Kenya as having eliminated human African trypanosomiasis (HAT), also known as sleepin

2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes

From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D), according to

ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes

Attention-deficit hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality, substance misu

Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes

Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury (RHI), acco

26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024

In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief